Cargando…

Fragment-Based Screening Maps Inhibitor Interactions in the ATP-Binding Site of Checkpoint Kinase 2

Checkpoint kinase 2 (CHK2) is an important serine/threonine kinase in the cellular response to DNA damage. A fragment-based screening campaign using a combination of a high-concentration AlphaScreen™ kinase assay and a biophysical thermal shift assay, followed by X-ray crystallography, identified a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva-Santisteban, M. Cris, Westwood, Isaac M., Boxall, Kathy, Brown, Nathan, Peacock, Sam, McAndrew, Craig, Barrie, Elaine, Richards, Meirion, Mirza, Amin, Oliver, Antony W., Burke, Rosemary, Hoelder, Swen, Jones, Keith, Aherne, G. Wynne, Blagg, Julian, Collins, Ian, Garrett, Michelle D., van Montfort, Rob L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680490/ https://www.ncbi.nlm.nih.gov/pubmed/23776527 http://dx.doi.org/10.1371/journal.pone.0065689

Ejemplares similares

Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates
por: Liu, Manjuan, et al.
Publicado: (2018)

Benzimidazole inhibitors of the protein kinase CHK2: Clarification of the binding mode by flexible side chain docking and protein–ligand crystallography
por: Matijssen, Cornelis, et al.
Publicado: (2012)

Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization
por: Whelligan, Daniel K., et al.
Publicado: (2010)

Structure-Based Design of Orally Bioavailable 1H-Pyrrolo[3,2-c]pyridine Inhibitors of Mitotic Kinase Monopolar Spindle 1 (MPS1)
por: Naud, Sébastien, et al.
Publicado: (2013)

Determination of Ligand-Binding Affinity (K(d)) Using Transverse Relaxation Rate (R(2)) in the Ligand-Observed (1)H NMR Experiment and Applications to Fragment-Based Drug Discovery
por: Liu, Manjuan, et al.
Publicado: (2023)

Structure‐Enabled Discovery of a Stapled Peptide Inhibitor to Target the Oncogenic Transcriptional Repressor TLE1
por: McGrath, Sally, et al.
Publicado: (2017)

A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms
por: Jones, Alan M., et al.
Publicado: (2016)

Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer
por: Clarke, Paul A., et al.
Publicado: (2019)

The discovery of potent ribosomal S6 kinase inhibitors by high-throughput screening and structure-guided drug design
por: Couty, Sylvain, et al.
Publicado: (2013)

Diverse Functionalization of Aurora-A Kinase at Specified Surface and Buried Sites by Native Chemical Modification
por: Rowan, Fiona, et al.
Publicado: (2014)

Scaffold-Focused Virtual Screening: Prospective Application to the Discovery of TTK Inhibitors
por: Langdon, Sarah R., et al.
Publicado: (2013)

Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy
por: Faisal, Amir, et al.
Publicado: (2017)

Introduction of a Methyl Group Curbs Metabolism of Pyrido[3,4-d]pyrimidine Monopolar Spindle 1 (MPS1) Inhibitors and Enables the Discovery of the Phase 1 Clinical Candidate N(2)-(2-Ethoxy-4-(4-methyl-4H-1,2,4-triazol-3-yl)phenyl)-6-methyl-N(8)-neopentylpyrido[3,4-d]pyrimidine-2,8-diamine (BOS172722)
por: Woodward, Hannah L., et al.
Publicado: (2018)

Insights into Aurora-A Kinase Activation Using Unnatural Amino Acids Incorporated by Chemical Modification
por: Rowan, Fiona C., et al.
Publicado: (2013)

Discovery of small molecule cancer drugs: Successes, challenges and opportunities
por: Hoelder, Swen, et al.
Publicado: (2012)

Microfluidic Mobility Shift Assay for Real-Time Analysis of Peptide N-Palmitoylation
por: Lanyon-Hogg, Thomas, et al.
Publicado: (2017)

Druggability Analysis and Structural Classification of Bromodomain Acetyl-lysine Binding Sites
por: Vidler, Lewis R., et al.
Publicado: (2012)

Mechanism-Based Screen for G1/S Checkpoint Activators Identifies a Selective Activator of EIF2AK3/PERK Signalling
por: Stockwell, Simon R., et al.
Publicado: (2012)

An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9
por: Richards, Mark W., et al.
Publicado: (2009)

Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response
por: Ali, Maruf M U, et al.
Publicado: (2011)

Into Deep Water: Optimizing BCL6 Inhibitors by Growing into a Solvated Pocket
por: Lloyd, Matthew G., et al.
Publicado: (2021)

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors
por: Davis, Owen A., et al.
Publicado: (2022)

Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing
por: Reader, John C., et al.
Publicado: (2011)

Novel Quinazolinone Inhibitors of ALK2 Flip between Alternate Binding Modes: Structure–Activity Relationship, Structural Characterization, Kinase Profiling, and Cellular Proof of Concept
por: Hudson, Liam, et al.
Publicado: (2018)

5-Hydroxytryptamine, Glutamate, and ATP: Much More Than Neurotransmitters
por: Franco, Rafael, et al.
Publicado: (2021)

Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition
por: Fearon, Daren, et al.
Publicado: (2018)

Discovery of an In Vivo Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones
por: Harnden, Alice C., et al.
Publicado: (2023)

Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
por: Chessum, Nicola E. A., et al.
Publicado: (2017)

Nitrite lowers the oxygen cost of ATP supply in cultured skeletal muscle cells by stimulating the rate of glycolytic ATP synthesis
por: Wynne, Anthony G., et al.
Publicado: (2022)

Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1
por: Wilding, Birgit, et al.
Publicado: (2021)

Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70
por: Cheeseman, Matthew D., et al.
Publicado: (2016)

Cruentaren A Binds F(1)F(0) ATP Synthase To Modulate the Hsp90 Protein Folding Machinery
por: Hall, Jessica A., et al.
Publicado: (2014)

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 In Vivo
por: Huckvale, Rosemary, et al.
Publicado: (2022)

Designing Dual Inhibitors of Anaplastic Lymphoma Kinase (ALK) and Bromodomain-4 (BRD4) by Tuning Kinase Selectivity
por: Watts, Ellen, et al.
Publicado: (2019)

Insights into the Conformational Variability and Regulation of Human Nek2 Kinase
por: Westwood, Isaac, et al.
Publicado: (2009)

Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays
por: Pierrat, Olivier A., et al.
Publicado: (2022)

Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors
por: Lainchbury, Michael, et al.
Publicado: (2012)

Knowledge gaps and educational needs of Veterans Affairs healthcare providers regarding COVID-19 at the start of the pandemic
por: Krupka, Chana B., et al.
Publicado: (2022)

Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders
por: Bellenie, Benjamin R., et al.
Publicado: (2020)

Finding the needle in the haystack: why high-throughput screening is good for your health
por: Aherne, G Wynne, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_d3m37hbpun9uvkvp1bnq2tdkue